Avalon GloboCare Corp. (ALBT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Avalon GloboCare Corp. (ALBT) has a cash flow conversion efficiency ratio of -0.021x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-192.06K) by net assets ($9.23 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Avalon GloboCare Corp. - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Avalon GloboCare Corp.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ALBT current and long-term liabilities for a breakdown of total debt and financial obligations.
Avalon GloboCare Corp. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Avalon GloboCare Corp. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Health and Plant Protein Group Ltd
AU:HPP
|
-0.067x |
|
Ucommune International Ltd
NASDAQ:UK
|
-0.017x |
|
OZZ Resources Ltd
AU:OZZ
|
0.105x |
|
KWESST Micro Systems Inc. Common Stock
NASDAQ:KWE
|
-0.237x |
|
Inomin Mines Inc
V:MINE
|
-0.133x |
|
AFRICAN PIONEER PLC O.N.
F:9TI
|
N/A |
|
Euro Kapital Yatirim Ortakligi AS
IS:EUKYO
|
0.003x |
|
Marula Mining PLC
F:48U0
|
N/A |
Annual Cash Flow Conversion Efficiency for Avalon GloboCare Corp. (2015–2025)
The table below shows the annual cash flow conversion efficiency of Avalon GloboCare Corp. from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Avalon GloboCare Corp. worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $9.23 Million | $-4.99 Million | -0.540x | +22.76% |
| 2024-12-31 | $7.10 Million | $-4.97 Million | -0.700x | +20.74% |
| 2023-12-31 | $7.37 Million | $-6.50 Million | -0.883x | -39.98% |
| 2022-12-31 | $11.16 Million | $-7.04 Million | -0.631x | +61.29% |
| 2021-12-31 | $3.08 Million | $-5.02 Million | -1.629x | +11.13% |
| 2020-12-31 | $4.12 Million | $-7.55 Million | -1.833x | -15.60% |
| 2019-12-31 | $4.47 Million | $-7.08 Million | -1.586x | -305.92% |
| 2018-12-31 | $11.25 Million | $-4.40 Million | -0.391x | -113.11% |
| 2017-12-31 | $7.31 Million | $-1.34 Million | -0.183x | -4748.22% |
| 2016-12-31 | $3.55 Million | $13.98K | 0.004x | -99.93% |
| 2015-12-31 | $-5.41K | $-30.11K | 5.569x | -- |
About Avalon GloboCare Corp.
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps users monitor and manage ketogenic diet and related programs. Avalon GloboCare Corp. was founded in… Read more